obinutuzumab,rituximab,chlorambucil,bendamustine,venetoclax
roche,abbvie
['venclexta', 'cll14', 'murano', 'venetoclax', 'cll', '$abbv']
$abbv's venclyxto/venclexta (venetoclax) continues to show sustained pfs in cll #eha2023 *cll14
pfs hr 0.40 - 95%ci[0.31-0.52] for ven+obi
umrd 53.1% ven+obi vs 21.7% ctrl *murano
mpfs 54.7mo ven+rtx vs 17.0mo ctrl - hr 0.23
7y-os 69.6% vs 51% - hr 0.53 
Biotellytics / https://t.co/37itIfRolp = business intel service on listed European Bios / Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design)